<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2026-71-2-66-77</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-2381</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Значение ликвор-сывороточных индексов интерлейкинов-6, -8, -10 в дифференциальной диагностике менингитов у детей</article-title><trans-title-group xml:lang="en"><trans-title>The significance of Cerebrospinal fluid/Serum ratios of interleukins-6, -8, -10 in the differential diagnosis of meningitis in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2137-2749</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демкина</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Deomkina</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демкина Александра Михайловна — аспирант кафедры инфекционных болезней у детей Института материнства и детства</p><p>117997, г. Москва, ул. Островитянова, дом 1 </p></bio><bio xml:lang="en"><p>117997, Moscow </p></bio><email xlink:type="simple">sasha.deomkina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0191-3728</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сайфуллин</surname><given-names>Р. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Sayfullin</surname><given-names>R. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сайфуллин Руслан Фаридович — к.м.н., доцент кафедры инфекционных болезней у детей Института материнства и детства; старший научный сотрудник</p><p>117997, г. Москва, ул. Островитянова, дом 1 </p></bio><bio xml:lang="en"><p>117997, Moscow </p><p>107031, Moscow </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3417-3631</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шакарян</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Shakaryan</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шакарян Армен Каренович — научный сотрудник клинического отдела; ассистент кафедры инфекционных болезней у детей Института материнства и детства;  врач–педиатр </p><p>117997, г. Москва, ул. Островитянова, дом 1 </p></bio><bio xml:lang="en"><p>117997, Moscow </p><p>108819, Moscow </p><p>125310, Moscow </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5555-3882</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусева</surname><given-names>Г. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Guseva</surname><given-names>G. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гусева Галина Дмитриевна — к.м.н., заведующая инфекционным отделением для детей с нейроинфекциями и менингитом</p><p>125310, г. Москва, Волоколамское шоссе, дом 63, строение 2 </p></bio><bio xml:lang="en"><p>125310, Moscow </p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-4662-8842</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горьков</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorkov</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горьков Тимофей Викторович — заведующий отделением реанимации и интенсивной терапии</p><p>125310, г. Москва, Волоколамское шоссе, дом 63, строение 2 </p></bio><bio xml:lang="en"><p>125310, Moscow </p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6033-6695</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шамшева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shamsheva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шамшева Ольга Васильевна — д.м.н., профессор, заведующий кафедрой инфекционных болезней у детей</p><p>117997, г. Москва, ул. Островитянова, дом 1 </p></bio><bio xml:lang="en"><p>117997, Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Министерства здравоохранения Российской Федерации ; ФГБНУ «Федеральный научно-клинический центр реаниматологии и реабилитологии» Минобрнауки России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. I. Pirogov Russian National Research Medical University ; Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology,Ministry of Education and Science of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Министерства здравоохранения Российской Федерации ; ФГАНУ «Федеральный научный центр исследований и разработки иммунобиологических препаратов им. М.П. Чумакова РАН» (Институт полиомиелита) ; ГБУЗ «Инфекционная клиническая больница № 1 Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. I. Pirogov Russian National Research Medical University ; Chumakov Federal Scientific Center for Research and Development of Immunobiological Products of Russian Academy of Sciences (Institute of Poliomyelitis) ; Infectious Clinical Hospital № 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ГБУЗ «Инфекционная клиническая больница № 1 Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Infectious Clinical Hospital № 1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>25</day><month>04</month><year>2026</year></pub-date><volume>71</volume><issue>2</issue><fpage>66</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/2381">https://www.ped-perinatology.ru/jour/article/view/2381</self-uri><abstract><p>Менингит — грозное заболевание, корректная стартовая терапия которого улучшает прогноз. Выбор тактики при этом зависит от этиологии: бактериальной или вирусной. Однако быстрая этиологическая расшифровка не всегда возможна, что обусловливает актуальность изучения других дифференциально-диагностических маркеров, в частности цитокинов, на ранних сроках менингита.</p><sec><title>Цель исследования</title><p>Цель исследования: определить дифференциально-диагностическую роль ликвор-сывороточных индексов интерлейкинов 6, 8, 10 при бактериальных гнойных и вирусных менингитах у детей.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В проспективное исследование вошли 63 ребенка, распределенных на группы бактериальных (n=20), вирусных (n=17) менингитов и контрольную группу (n=26). Были определены концентрации альбумина и интерлейкинов 6, 8, 10 в полученных параллельно в день поступления в стационар ликворе и сыворотке и рассчитаны ликвор-сывороточные индексы (QAlb, QIL). Выполнен ROC-анализ с оценкой площади под кривой (AUC) и определением пороговых значений; разработана прогностическая модель методом бинарной логистической регрессии.</p></sec><sec><title>Результаты</title><p>Результаты. Высокой диагностической значимостью для дифференцирования бактериальных и вирусных менингитов обладали концентрации интерлейкина 6 в ликворе (AUC=0,982) и сыворотке (AUC=0,991), интерлейкина 10 в сыворотке (AUC=0,965); QIL10 (AUC=0,953; чувствительность 95,0%, специфичность 76,5%). Комбинирование QAlb и QIL10 в уравнении прогностической модели повысило чувствительность (100%) и специфичность (88,2%). Предложен возможный механизм интратекальной регуляции воспаления на ранних сроках менингитов. При бактериальных менингитах интратекально синтезируются только провоспалительные интерлейкины 6 и 8, что объясняет нейтрофильный плеоцитоз. При вирусных менингитах интратекальная продукция интерлейкинов 6, 8 и противовоспалительного интерлейкина 10, угнетающего миграцию нейтрофилов в ликвор, обусловливают смешанный или лимфоцитарный плеоцитоз.</p></sec><sec><title>Заключение</title><p>Заключение. Оценка концентрации интерлейкина 6 в ликворе и использование представленной в статье формулы, включающей QAlb и QIL10, позволяют дифференцировать бактериальные и вирусные менингиты у детей на ранних сроках.</p></sec></abstract><trans-abstract xml:lang="en"><p>Meningitis is a devastating disease for which appropriate initial treatment improves outcome. Management strategies are based on the etiology, which is most commonly bacterial or viral. However, prompt detection of the etiologic agent is not possible in all cases; therefore, the investigation of additional early differential diagnostic markers, such as interleukins, remains relevant.</p><sec><title>The aim of the study</title><p>The aim of the study. To determine the differential diagnostic value of cerebrospinal fluid/serum ratios of interleukins 6, 8, 10 in purulent bacterial and viral meningitis in children.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. This prospective study enrolled 63 children, divided into three groups: bacterial meningitis (n=20), viral meningitis (n=17), and a control group (n=26). Concentrations of albumin, interleukins 6, 8, 10 were evaluated in cerebrospinal fluid and serum samples obtained in parallel on the day of admission. Cerebrospinal fluid/serum ratios (QAlb and QIL) were calculated. Receiver operating characteristic (ROC) curve analysis was performed with estimation of the area under the curve (AUC) and determination of optimal cut-off values. A predictive model was developed with binary logistic regression.</p></sec><sec><title>Results</title><p>Results. Interleukin 6 concentrations in cerebrospinal fluid (AUC = 0.982) and serum (AUC = 0.991), serum interleukin 10 (AUC = 0.965), and QIL10 (AUC = 0.953; sensitivity = 95.0%, specificity = 76.5%) demonstrated high diagnostic accuracy in differentiating bacterial from viral meningitis. Combining QAlb and QIL10 in the predictive model equation increased sensitivity (100%) and specificity (88.2%). A possible mechanism of intrathecal regulation of inflammation in the early stages of meningitis is proposed. In bacterial meningitis, only pro-inflammatory interleukins 6 and 8 are synthesized intrathecally, resulting in neutrophilic pleocytosis. In viral meningitis, intrathecal production of interleukins 6 and 8 and anti-inflammatory interleukin 10 inhibiting neutrophil recruitment into the cerebrospinal fluid leads to mixed or lymphocytic pleocytosis.</p></sec><sec><title>Conclusion</title><p>Conclusion. Evaluation of interleukin 6 concentration in cerebrospinal fluid and application of the predictive formula incorporating QAlb and QIL10 enables differentiation between bacterial and viral meningitis at the early stages of the disease.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>менингит</kwd><kwd>интерлейкин</kwd><kwd>индекс</kwd><kwd>интратекальный синтез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>meningitis</kwd><kwd>interleukin</kwd><kwd>index</kwd><kwd>intrathecal synthesis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Skar G., Flannigan L., Latch R., Snowden J. Meningitis in Children: Still a Can’t-Miss Diagnosis. Pediatr Rev. 2024; 45(6): 305–315. DOI: 10.1542/pir.2023-006013</mixed-citation><mixed-citation xml:lang="en">Skar G., Flannigan L., Latch R., Snowden J. Meningitis in Children: Still a Can’t-Miss Diagnosis. Pediatr Rev. 2024; 45(6): 305–315. DOI: 10.1542/pir.2023-006013</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">van de Beek D., Cabellos C., Dzupova O., Esposito S., Klein M., Kloek A.T. et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016; 22 Suppl 3: S37-S62. DOI: 10.1016/j.cmi.2016.01.007</mixed-citation><mixed-citation xml:lang="en">van de Beek D., Cabellos C., Dzupova O., Esposito S., Klein M., Kloek A.T. et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016; 22 Suppl 3: S37-S62. DOI: 10.1016/j.cmi.2016.01.007</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ivaska L., Herberg J., Sadarangani M. Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers. J Infect. 2024; 88(3): 106–111. DOI: 10.1016/j.jinf.2024.01.010</mixed-citation><mixed-citation xml:lang="en">Ivaska L., Herberg J., Sadarangani M. Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers. J Infect. 2024; 88(3): 106–111. DOI: 10.1016/j.jinf.2024.01.010</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Groeneveld N.S., Bijlsma M.W., van de Beek D., Brouwer M.C. Biomarkers in paediatric bacterial meningitis: a systematic review and meta-analysis of diagnostic test accuracy. Clin Microbiol Infect. 2025; 31(5): 702–712. DOI: 10.1016/j.cmi.2024.12.009</mixed-citation><mixed-citation xml:lang="en">Groeneveld N.S., Bijlsma M.W., van de Beek D., Brouwer M.C. Biomarkers in paediatric bacterial meningitis: a systematic review and meta-analysis of diagnostic test accuracy. Clin Microbiol Infect. 2025; 31(5): 702–712. DOI: 10.1016/j.cmi.2024.12.009</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kalchev Y., Argirova P., Boev I., Yaneva A., Vatev N., Stoycheva M. et al. Cytokine profile in patients with acute bacterial meningitis. Cytokine. 2023; 170:156315. DOI: 10.1016/j.cyto.2023.156315</mixed-citation><mixed-citation xml:lang="en">Kalchev Y., Argirova P., Boev I., Yaneva A., Vatev N., Stoycheva M. et al. Cytokine profile in patients with acute bacterial meningitis. Cytokine. 2023; 170:156315. DOI: 10.1016/j.cyto.2023.156315</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto Junior V.L., Rebelo M.C., Gomes R.N., Assis E.F., Castro-Faria-Neto H.C., Bóia M.N. IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis. Braz J Infect Dis. 2011; 15(2): 156–158. DOI: 10.1590/s1413-86702011000200011</mixed-citation><mixed-citation xml:lang="en">Pinto Junior V.L., Rebelo M.C., Gomes R.N., Assis E.F., Castro-Faria-Neto H.C., Bóia M.N. IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis. Braz J Infect Dis. 2011; 15(2): 156–158. DOI: 10.1590/s1413-86702011000200011</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Reiber H. Liquordiagnostik in der Neurologie: Paradigmenwechsel bei Hirn-Schranken, Immunsystem und chronischen Krankheiten (essentials). Berlin; Springer, 2023; 75. DOI: 10.1007/978-3-662-68136-7</mixed-citation><mixed-citation xml:lang="en">Reiber H. Liquordiagnostik in der Neurologie: Paradigmenwechsel bei Hirn-Schranken, Immunsystem und chronischen Krankheiten (essentials). Berlin; Springer, 2023; 75. DOI: 10.1007/978-3-662-68136-7</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001; 184(2): 101–122. DOI: 10.1016/s0022-510x(00)00501-3</mixed-citation><mixed-citation xml:lang="en">Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001; 184(2): 101–122. DOI: 10.1016/s0022-510x(00)00501-3</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann K., Kühn H.-J., Linke E. Praanalytik. ̈ Praktische Liquordiagnostik in Frage und Antwort. Düsseldorf, 2014; 10–18</mixed-citation><mixed-citation xml:lang="en">Zimmermann K., Kühn H.-J., Linke E. Praanalytik. ̈ Praktische Liquordiagnostik in Frage und Antwort. Düsseldorf, 2014; 10–18</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sullivan M.A., Lane S.D., McKenzie A.D.J., Ball S.R., Sunde M., Neely G.G. et al. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype. J Neuroinflammation. 2024; 21(1): 7. DOI: 10.1186/s12974-023-02951-2</mixed-citation><mixed-citation xml:lang="en">Sullivan M.A., Lane S.D., McKenzie A.D.J., Ball S.R., Sunde M., Neely G.G. et al. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype. J Neuroinflammation. 2024; 21(1): 7. DOI: 10.1186/s12974-023-02951-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Strle K., Zhou J.H., Shen W.H., Broussard S.R., Johnson R.W., Freund G.G. et al. Interleukin-10 in the brain. Crit Rev Immunol. 2001; 21(5): 427–449.</mixed-citation><mixed-citation xml:lang="en">Strle K., Zhou J.H., Shen W.H., Broussard S.R., Johnson R.W., Freund G.G. et al. Interleukin-10 in the brain. Crit Rev Immunol. 2001; 21(5): 427–449.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Демкина А.М., Сайфуллин Р.Ф., Шакарян А.К., Шамшева О.В. Ликвор-сывороточные индексы: современный подход к оценке интратекального воспаления. Инфекция и иммунитет 2025; 15(4): 625–634. DOI: 10.15789/2220-7619-CSR-17927</mixed-citation><mixed-citation xml:lang="en">Deomkina A.M., Sayfullin R.F., Shakaryan A.K., Shamsheva O.V. CSF/serum ratios: modern approach to assess intrathecal response. Infekciya i immunitet 2025; 15(4): 625–634. (in Russ.). DOI: 10.15789/2220-7619-CSR-17927</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ausgewählte Methoden der Liquordiagnostik und Klinischen Neurochemie. Germany: Deutsche Gesellschaft für Liquordiagnostik und Klinische Neurochemie e.V. 2020; 100 p. https://www.dgln.de/methodenkatalog</mixed-citation><mixed-citation xml:lang="en">Ausgewählte Methoden der Liquordiagnostik und Klinischen Neurochemie. Germany: Deutsche Gesellschaft für Liquordiagnostik und Klinische Neurochemie e.V. 2020; 100 p. https://www.dgln.de/methodenkatalog</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">ARUP Laboratories. Cytokine Panel 13, CSF. https://www.aruplab.com/Testing-Information/resources/HotLines/HotLineDocs/Feb2021/3003259.pdf. Ссылка активна на 22.01.2026</mixed-citation><mixed-citation xml:lang="en">ARUP Laboratories. Cytokine Panel 13, CSF. https://www.aruplab.com/Testing-Information/resources/HotLines/HotLineDocs/Feb2021/3003259.pdf. Ссылка активна на 22.01.2026</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Caragheorgheopol R., Țucureanu C., Lazăr V., Florescu S.A., Lazăr D.S., Caraş I. Cerebrospinal fluid cytokines and chemokines exhibit distinct profiles in bacterial meningitis and viral meningitis. Exp Ther Med. 2023; 25(5): 204. DOI: 10.3892/etm.2023.11903</mixed-citation><mixed-citation xml:lang="en">Caragheorgheopol R., Țucureanu C., Lazăr V., Florescu S.A., Lazăr D.S., Caraş I. Cerebrospinal fluid cytokines and chemokines exhibit distinct profiles in bacterial meningitis and viral meningitis. Exp Ther Med. 2023; 25(5): 204. DOI: 10.3892/etm.2023.11903</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">StatTech. Онлайн-калькуляторы статистических расчетов размера выборки. https://stattech.ru/calculators. Ссылка активна на 22.01.2026</mixed-citation><mixed-citation xml:lang="en">StatTech. Онлайн-калькуляторы статистических расчетов размера выборки. https://stattech.ru/calculators. Ссылка активна на 22.01.2026</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen J.F., Korevaar D.A., Altman D.G., Bruns D.E., Gatsonis C.A., Hooft L. et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016; 6(11): e012799. DOI: 10.1136/bmjopen-2016-012799</mixed-citation><mixed-citation xml:lang="en">Cohen J.F., Korevaar D.A., Altman D.G., Bruns D.E., Gatsonis C.A., Hooft L. et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016; 6(11): e012799. DOI: 10.1136/bmjopen-2016-012799</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Olie S.E., Staal S.L., Ter Horst L., van Zeggeren I.E., Man W.K., Tanck M.W.T. et al. Diagnostic accuracy of inflammatory markers in adults with suspected central nervous system infections. J Infect. 2024; 88(3): 106–117. DOI: 10.1016/j.jinf.2024.01.016</mixed-citation><mixed-citation xml:lang="en">Olie S.E., Staal S.L., Ter Horst L., van Zeggeren I.E., Man W.K., Tanck M.W.T. et al. Diagnostic accuracy of inflammatory markers in adults with suspected central nervous system infections. J Infect. 2024; 88(3): 106–117. DOI: 10.1016/j.jinf.2024.01.016</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tan C.D., van den Broek B., Womersley R.S., Kaforou M., Hagedoorn N.N., van der Flier M. et al. A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency Care. Pediatr Infect Dis J. 2023; 42(7): e235-e242. DOI: 10.1097/INF.0000000000003952</mixed-citation><mixed-citation xml:lang="en">Tan C.D., van den Broek B., Womersley R.S., Kaforou M., Hagedoorn N.N., van der Flier M. et al. A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency Care. Pediatr Infect Dis J. 2023; 42(7): e235-e242. DOI: 10.1097/INF.0000000000003952</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012; 8(9): 1254–1266. DOI: 10.7150/ijbs.4679</mixed-citation><mixed-citation xml:lang="en">Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012; 8(9): 1254–1266. DOI: 10.7150/ijbs.4679</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Matsushima K., Yang D., Oppenheim J.J. Interleukin-8: An evolving chemokine. Cytokine. 2022; 153: 155828. DOI: 10.1016/j.cyto.2022.155828</mixed-citation><mixed-citation xml:lang="en">Matsushima K., Yang D., Oppenheim J.J. Interleukin-8: An evolving chemokine. Cytokine. 2022; 153: 155828. DOI: 10.1016/j.cyto.2022.155828</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Patilas C., Varsamos I., Galanis A., Vavourakis M., Zachariou D., Marougklianis V. et al. The Role of Interleukin-10 in the Pathogenesis and Treatment of a Spinal Cord Injury. Diagnostics (Basel). 2024; 14(2): 151. DOI: 10.3390/diagnostics14020151</mixed-citation><mixed-citation xml:lang="en">Patilas C., Varsamos I., Galanis A., Vavourakis M., Zachariou D., Marougklianis V. et al. The Role of Interleukin-10 in the Pathogenesis and Treatment of a Spinal Cord Injury. Diagnostics (Basel). 2024; 14(2): 151. DOI: 10.3390/diagnostics14020151</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
